Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Endocyte Inc (NASDAQ:ECYT)

4.94
Delayed Data
As of Dec 08
 +0.16 / +3.35%
Today’s Change
1.17
Today|||52-Week Range
6.55
+93.73%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Revenue and IncomeNet Revenues12.0K12.5K12.5K32.5K
 
 
 
 
 
Depreciation And Amortization240.1K238.3K230.6K232.1K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses11.0M11.5M9.4M6.9M
 
 
 
 
 
Research And Development8.2M8.0M6.5M4.1M
 
 
 
 
 
Total Operating Expenses11.3M11.7M9.7M7.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-11.3M-11.7M-9.6M-7.1M
 
 
 
 
 
Extraordinary Charge0.000.00-2.3M-16.5M
 
 
 
Other Expenses-25.0K3.2K-30.6K29.7K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-11.1M-11.5M-11.7M-23.3M
 
 
 
 
 
Net Income-11.1M-11.5M-11.7M-23.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS42.3M42.4M42.5M42.6M
 
 
 
 
 
Shares To Calculate EPS Diluted42.3M42.4M42.5M42.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.26-$0.27-$0.28-$0.55
 
 
 
 
 
EPS Diluted-$0.26-$0.27-$0.28-$0.55